Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential: https://g.foolcdn.com/editorial/images/776921/gettyimages-1441663123-1200x803-37403b6.jpg
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential

Your long-term investment portfolio should have meaningful exposure to healthcare stocks. People will always seek treatments for disease, so demand for the sector won't go away any time soon

2 Reasons Amazon Stock Is a Buy and Hold Forever: https://g.foolcdn.com/editorial/images/775785/gettyimages-1131198259.jpg
2 Reasons Amazon Stock Is a Buy and Hold Forever

Amazon (NASDAQ: AMZN) is one of the largest companies on earth. For much of the world, especially the U.S., it's difficult to go a day without seeing one of the company's drivers making a delivery

3 Magnificent Stocks That Are Passive Income Machines: https://g.foolcdn.com/editorial/images/776733/physician-shaking-patients-hand.jpg
3 Magnificent Stocks That Are Passive Income Machines

There are many dividend stocks on the market. Some will eventually cut or suspend their payouts due to company-specific, economic, or broader market issues. Those aren't the kind of dividend stocks

Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?: https://g.foolcdn.com/editorial/images/777124/wall-street-analyst-with-laptop-getty.jpg
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?

Shares of the struggling vaccine developer Novavax (NASDAQ: NVAX) bounded 98.7% higher on Friday, May 10. The market was responding to terrific news from Sanofi (NASDAQ: SNY), a global

What Is the Dividend Payout for AbbVie Stock?: https://g.foolcdn.com/editorial/images/776819/financial-analysis-company-filing-business-papers.jpg
What Is the Dividend Payout for AbbVie Stock?

Many investors hold a stake in AbbVie (NYSE: ABBV) because it offers exposure to the healthcare sector. Industry-based diversification, however, isn't all the pharmaceutical outfit brings to the

How Viking Therapeutics Stock Could 30x: https://g.foolcdn.com/editorial/images/777044/growth-curve.jpg
How Viking Therapeutics Stock Could 30x

Viking Therapeutics (NASDAQ: VKTX) has been one of the few bright spots in the healthcare sector this year. The biotech's shares have stormed higher by almost 300% year to date on the back of its

Is Viking Therapeutics the Best Biotech Stock for You?: https://g.foolcdn.com/editorial/images/776215/scientist-looks-into-microscope-while-sitting-at-lab-bench.jpg
Is Viking Therapeutics the Best Biotech Stock for You?

Viking Therapeutics (NASDAQ: VKTX) isn't a household name, but if its plans to commercialize a powerful anti-obesity medicine come to fruition, it may well become one. Though it has yet to

Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock: https://g.foolcdn.com/editorial/images/776741/dna-genetic-sequencing-biotech-1200x675-128554e.jpg
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock

Pfizer (NYSE: PFE) stock has struggled over the past year, losing around 28% of its value. Its dividend payout, meanwhile, has continued to rise again and again. This combination has pushed the

Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock: https://g.foolcdn.com/editorial/images/776741/dna-genetic-sequencing-biotech-1200x675-128554e.jpg
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock

Pfizer (NYSE: PFE) stock has struggled over the past year, losing around 28% of its value. Its dividend payout, meanwhile, has continued to rise again and again. This combination has pushed the

Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy: https://g.foolcdn.com/editorial/images/776494/patient-taking-medicine.jpg
Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy

There are several textbook arguments against monopolies. According to one of them, companies that control a market can lower the quality of their products with impunity.

However, Vertex

Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy: https://g.foolcdn.com/editorial/images/776494/patient-taking-medicine.jpg
Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy

There are several textbook arguments against monopolies. According to one of them, companies that control a market can lower the quality of their products with impunity.

However, Vertex

Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy: https://g.foolcdn.com/editorial/images/776494/patient-taking-medicine.jpg
Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy

There are several textbook arguments against monopolies. According to one of them, companies that control a market can lower the quality of their products with impunity.

However, Vertex

Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?: https://g.foolcdn.com/editorial/images/776121/physician-talking-to-patient.jpg
Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?

Many billionaire investors are going all in on artificial intelligence (AI). That's understandable. AI is quickly being integrated into businesses' day-to-day operations. The leaders in the field

2 Unbelievable Growth Stocks You Can Buy and Hold for the Next Decade: https://g.foolcdn.com/editorial/images/776335/getty-finger-on-lips-quiet-secret.jpg
2 Unbelievable Growth Stocks You Can Buy and Hold for the Next Decade

The stock market has taken investors for a wild ride these last few years. When you're investing in stocks for many years, though, even multiple tough market cycles shouldn't deter you from your

2 Unbelievable Growth Stocks You Can Buy and Hold for the Next Decade: https://g.foolcdn.com/editorial/images/776335/getty-finger-on-lips-quiet-secret.jpg
2 Unbelievable Growth Stocks You Can Buy and Hold for the Next Decade

The stock market has taken investors for a wild ride these last few years. When you're investing in stocks for many years, though, even multiple tough market cycles shouldn't deter you from your

2 Unbelievable Growth Stocks You Can Buy and Hold for the Next Decade: https://g.foolcdn.com/editorial/images/776335/getty-finger-on-lips-quiet-secret.jpg
2 Unbelievable Growth Stocks You Can Buy and Hold for the Next Decade

The stock market has taken investors for a wild ride these last few years. When you're investing in stocks for many years, though, even multiple tough market cycles shouldn't deter you from your

Amgen Is Working On a Wegovy Competitor -- What It Means for Investors: https://g.foolcdn.com/editorial/images/776246/physician-shaking-patients-hand.jpg
Amgen Is Working On a Wegovy Competitor -- What It Means for Investors

It's a race to the riches in the anti-obesity drug market. This therapeutic area is projected to grow exponentially in the coming years. Novo Nordisk is one of the clear market leaders -- for now --

Amgen Is Working On a Wegovy Competitor -- What It Means for Investors: https://g.foolcdn.com/editorial/images/776246/physician-shaking-patients-hand.jpg
Amgen Is Working On a Wegovy Competitor -- What It Means for Investors

It's a race to the riches in the anti-obesity drug market. This therapeutic area is projected to grow exponentially in the coming years. Novo Nordisk is one of the clear market leaders -- for now --

Amgen Is Working On a Wegovy Competitor -- What It Means for Investors: https://g.foolcdn.com/editorial/images/776246/physician-shaking-patients-hand.jpg
Amgen Is Working On a Wegovy Competitor -- What It Means for Investors

It's a race to the riches in the anti-obesity drug market. This therapeutic area is projected to grow exponentially in the coming years. Novo Nordisk is one of the clear market leaders -- for now --

Prediction: These 2 Growth Stocks Could Triple By 2030: https://g.foolcdn.com/editorial/images/776119/doctor-holding-elderly-patients-hand.jpg
Prediction: These 2 Growth Stocks Could Triple By 2030

Stocks that can triple in six years aren't easy to find. Doing so requires a compound annual growth rate of 20.1%, well above the broader market's historical performance. However, it isn't

Earn $1000 Every Month From These 3 Stocks: https://g.foolcdn.com/editorial/images/776930/copy-of-dividends-blackboard-sketch-doodle.jpg
Earn $1000 Every Month From These 3 Stocks

When it comes to dividend investing, I am constantly looking for high-quality companies with strong free cash flows that pay safe, reliable, and growing dividends. In today's video, I will show you

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.: https://g.foolcdn.com/editorial/images/773559/novo_nordisk_flag_with_logo_nvo.jpg
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.

The healthcare industry is a fantastic place to find passive income. Healthcare is recession-proof, and there's always a need for better technology and new treatments. The industry's top dogs have

Why Novavax Stock More Than Doubled Today: https://g.foolcdn.com/editorial/images/776909/break-through-ceiling.jpg
Why Novavax Stock More Than Doubled Today

Shares of Novavax (NASDAQ: NVAX) are up 12% as of midday Friday following the release of the drugmaker's first-quarter results. It's not the report, however, driving the bulk of today's oversize

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought: https://g.foolcdn.com/editorial/images/776868/gettyimages-104212737.jpg
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Cathie Wood can't seem to string together back-to-back years of success. The Ark Invest co-founder and CEO became a rock star among aggressive growth investors in 2020, only to see her

2 Beaten-Down Stocks to Buy and Hold for 10 Years: https://g.foolcdn.com/editorial/images/775406/doctor-with-patient-talking.jpg
2 Beaten-Down Stocks to Buy and Hold for 10 Years

It's easy to find stocks that are lagging broader equities, even in a bull market like the one we're currently in. It's harder to find beaten-down stocks that still look worth buying and holding